Sepsis Diagnostic Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sepsis Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Laboratory Tests
1.2.3 Point-of-care Tests
1.3 Market by Application
1.3.1 Global Sepsis Diagnostic Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sepsis Diagnostic Market Perspective (2017-2028)
2.2 Sepsis Diagnostic Growth Trends by Region
2.2.1 Sepsis Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Sepsis Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 Sepsis Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 Sepsis Diagnostic Market Dynamics
2.3.1 Sepsis Diagnostic Industry Trends
2.3.2 Sepsis Diagnostic Market Drivers
2.3.3 Sepsis Diagnostic Market Challenges
2.3.4 Sepsis Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostic Players by Revenue
3.1.1 Global Top Sepsis Diagnostic Players by Revenue (2017-2022)
3.1.2 Global Sepsis Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global Sepsis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sepsis Diagnostic Revenue
3.4 Global Sepsis Diagnostic Market Concentration Ratio
3.4.1 Global Sepsis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostic Revenue in 2021
3.5 Sepsis Diagnostic Key Players Head office and Area Served
3.6 Key Players Sepsis Diagnostic Product Solution and Service
3.7 Date of Enter into Sepsis Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sepsis Diagnostic Breakdown Data by Type
4.1 Global Sepsis Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global Sepsis Diagnostic Forecasted Market Size by Type (2023-2028)
5 Sepsis Diagnostic Breakdown Data by Application
5.1 Global Sepsis Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Sepsis Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Sepsis Diagnostic Market Size (2017-2028)
6.2 North America Sepsis Diagnostic Market Size by Country (2017-2022)
6.3 North America Sepsis Diagnostic Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Sepsis Diagnostic Market Size (2017-2028)
7.2 Europe Sepsis Diagnostic Market Size by Country (2017-2022)
7.3 Europe Sepsis Diagnostic Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sepsis Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific Sepsis Diagnostic Market Size by Country (2017-2022)
8.3 Asia-Pacific Sepsis Diagnostic Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Sepsis Diagnostic Market Size (2017-2028)
9.2 Latin America Sepsis Diagnostic Market Size by Country (2017-2022)
9.3 Latin America Sepsis Diagnostic Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sepsis Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa Sepsis Diagnostic Market Size by Country (2017-2022)
10.3 Middle East & Africa Sepsis Diagnostic Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bruker (US)
11.1.1 Bruker (US) Company Detail
11.1.2 Bruker (US) Business Overview
11.1.3 Bruker (US) Sepsis Diagnostic Introduction
11.1.4 Bruker (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.1.5 Bruker (US) Recent Development
11.2 CytoSorbents (US)
11.2.1 CytoSorbents (US) Company Detail
11.2.2 CytoSorbents (US) Business Overview
11.2.3 CytoSorbents (US) Sepsis Diagnostic Introduction
11.2.4 CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.2.5 CytoSorbents (US) Recent Development
11.3 EKF (US)
11.3.1 EKF (US) Company Detail
11.3.2 EKF (US) Business Overview
11.3.3 EKF (US) Sepsis Diagnostic Introduction
11.3.4 EKF (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.3.5 EKF (US) Recent Development
11.4 T2 Biosystems (US)
11.4.1 T2 Biosystems (US) Company Detail
11.4.2 T2 Biosystems (US) Business Overview
11.4.3 T2 Biosystems (US) Sepsis Diagnostic Introduction
11.4.4 T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.4.5 T2 Biosystems (US) Recent Development
11.5 Luminex (US)
11.5.1 Luminex (US) Company Detail
11.5.2 Luminex (US) Business Overview
11.5.3 Luminex (US) Sepsis Diagnostic Introduction
11.5.4 Luminex (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.5.5 Luminex (US) Recent Development
11.6 Thermo Fisher Scientific (US)
11.6.1 Thermo Fisher Scientific (US) Company Detail
11.6.2 Thermo Fisher Scientific (US) Business Overview
11.6.3 Thermo Fisher Scientific (US) Sepsis Diagnostic Introduction
11.6.4 Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.6.5 Thermo Fisher Scientific (US) Recent Development
11.7 bioMerieux (France)
11.7.1 bioMerieux (France) Company Detail
11.7.2 bioMerieux (France) Business Overview
11.7.3 bioMerieux (France) Sepsis Diagnostic Introduction
11.7.4 bioMerieux (France) Revenue in Sepsis Diagnostic Business (2017-2022)
11.7.5 bioMerieux (France) Recent Development
11.8 Danaher (US)
11.8.1 Danaher (US) Company Detail
11.8.2 Danaher (US) Business Overview
11.8.3 Danaher (US) Sepsis Diagnostic Introduction
11.8.4 Danaher (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.8.5 Danaher (US) Recent Development
11.9 Becton, Dickinson and Company (US)
11.9.1 Becton, Dickinson and Company (US) Company Detail
11.9.2 Becton, Dickinson and Company (US) Business Overview
11.9.3 Becton, Dickinson and Company (US) Sepsis Diagnostic Introduction
11.9.4 Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.9.5 Becton, Dickinson and Company (US) Recent Development
11.10 Roche (Switzerland)
11.10.1 Roche (Switzerland) Company Detail
11.10.2 Roche (Switzerland) Business Overview
11.10.3 Roche (Switzerland) Sepsis Diagnostic Introduction
11.10.4 Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2017-2022)
11.10.5 Roche (Switzerland) Recent Development
11.11 Abbott (US)
11.11.1 Abbott (US) Company Detail
11.11.2 Abbott (US) Business Overview
11.11.3 Abbott (US) Sepsis Diagnostic Introduction
11.11.4 Abbott (US) Revenue in Sepsis Diagnostic Business (2017-2022)
11.11.5 Abbott (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Sepsis Diagnostic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Laboratory Tests
Table 3. Key Players of Point-of-care Tests
Table 4. Global Sepsis Diagnostic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Sepsis Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Sepsis Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Sepsis Diagnostic Market Share by Region (2017-2022)
Table 8. Global Sepsis Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Sepsis Diagnostic Market Share by Region (2023-2028)
Table 10. Sepsis Diagnostic Market Trends
Table 11. Sepsis Diagnostic Market Drivers
Table 12. Sepsis Diagnostic Market Challenges
Table 13. Sepsis Diagnostic Market Restraints
Table 14. Global Sepsis Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Sepsis Diagnostic Market Share by Players (2017-2022)
Table 16. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2021)
Table 17. Ranking of Global Top Sepsis Diagnostic Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Sepsis Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Sepsis Diagnostic Product Solution and Service
Table 21. Date of Enter into Sepsis Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Sepsis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Sepsis Diagnostic Revenue Market Share by Type (2017-2022)
Table 25. Global Sepsis Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Sepsis Diagnostic Revenue Market Share by Type (2023-2028)
Table 27. Global Sepsis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Sepsis Diagnostic Revenue Market Share by Application (2017-2022)
Table 29. Global Sepsis Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Sepsis Diagnostic Revenue Market Share by Application (2023-2028)
Table 31. North America Sepsis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Sepsis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Sepsis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Sepsis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Sepsis Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Sepsis Diagnostic Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Sepsis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Sepsis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Sepsis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Sepsis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 41. Bruker (US) Company Detail
Table 42. Bruker (US) Business Overview
Table 43. Bruker (US) Sepsis Diagnostic Product
Table 44. Bruker (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 45. Bruker (US) Recent Development
Table 46. CytoSorbents (US) Company Detail
Table 47. CytoSorbents (US) Business Overview
Table 48. CytoSorbents (US) Sepsis Diagnostic Product
Table 49. CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 50. CytoSorbents (US) Recent Development
Table 51. EKF (US) Company Detail
Table 52. EKF (US) Business Overview
Table 53. EKF (US) Sepsis Diagnostic Product
Table 54. EKF (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 55. EKF (US) Recent Development
Table 56. T2 Biosystems (US) Company Detail
Table 57. T2 Biosystems (US) Business Overview
Table 58. T2 Biosystems (US) Sepsis Diagnostic Product
Table 59. T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 60. T2 Biosystems (US) Recent Development
Table 61. Luminex (US) Company Detail
Table 62. Luminex (US) Business Overview
Table 63. Luminex (US) Sepsis Diagnostic Product
Table 64. Luminex (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 65. Luminex (US) Recent Development
Table 66. Thermo Fisher Scientific (US) Company Detail
Table 67. Thermo Fisher Scientific (US) Business Overview
Table 68. Thermo Fisher Scientific (US) Sepsis Diagnostic Product
Table 69. Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 70. Thermo Fisher Scientific (US) Recent Development
Table 71. bioMerieux (France) Company Detail
Table 72. bioMerieux (France) Business Overview
Table 73. bioMerieux (France) Sepsis Diagnostic Product
Table 74. bioMerieux (France) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 75. bioMerieux (France) Recent Development
Table 76. Danaher (US) Company Detail
Table 77. Danaher (US) Business Overview
Table 78. Danaher (US) Sepsis Diagnostic Product
Table 79. Danaher (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 80. Danaher (US) Recent Development
Table 81. Becton, Dickinson and Company (US) Company Detail
Table 82. Becton, Dickinson and Company (US) Business Overview
Table 83. Becton, Dickinson and Company (US) Sepsis Diagnostic Product
Table 84. Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 85. Becton, Dickinson and Company (US) Recent Development
Table 86. Roche (Switzerland) Company Detail
Table 87. Roche (Switzerland) Business Overview
Table 88. Roche (Switzerland) Sepsis Diagnostic Product
Table 89. Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 90. Roche (Switzerland) Recent Development
Table 91. Abbott (US) Company Detail
Table 92. Abbott (US) Business Overview
Table 93. Abbott (US) Sepsis DiagnosticProduct
Table 94. Abbott (US) Revenue in Sepsis Diagnostic Business (2017-2022) & (US$ Million)
Table 95. Abbott (US) Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sepsis Diagnostic Market Share by Type: 2021 VS 2028
Figure 2. Laboratory Tests Features
Figure 3. Point-of-care Tests Features
Figure 4. Global Sepsis Diagnostic Market Share by Application in 2021 & 2028
Figure 5. Hospitals Case Studies
Figure 6. Pathology & Reference Laboratories Case Studies
Figure 7. Sepsis Diagnostic Report Years Considered
Figure 8. Global Sepsis Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Sepsis Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Sepsis Diagnostic Market Share by Region: 2021 VS 2028
Figure 11. Global Sepsis Diagnostic Market Share by Players in 2021
Figure 12. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Diagnostic as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Sepsis Diagnostic Revenue in 2021
Figure 14. North America Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Sepsis Diagnostic Market Share by Country (2017-2028)
Figure 16. United States Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Sepsis Diagnostic Market Share by Country (2017-2028)
Figure 20. Germany Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Sepsis Diagnostic Market Share by Region (2017-2028)
Figure 28. China Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Sepsis Diagnostic Market Share by Country (2017-2028)
Figure 36. Mexico Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Sepsis Diagnostic Market Share by Country (2017-2028)
Figure 40. Turkey Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Sepsis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Bruker (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 43. CytoSorbents (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 44. EKF (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 45. T2 Biosystems (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 46. Luminex (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 47. Thermo Fisher Scientific (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 48. bioMerieux (France) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 49. Danaher (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 50. Becton, Dickinson and Company (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 51. Roche (Switzerland) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 52. Abbott (US) Revenue Growth Rate in Sepsis Diagnostic Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Industry Market Size
